Stereotaxis wins CE mark for Synchrony system, submits to FDA
Stereotaxis Receives CE Mark and Submits Synchrony System to FDA Stereotaxis (NYSE:STXS) announced that it has received CE mark for its Synchrony system and submitted it to the FDA.
Stereotaxis Receives CE Mark and Submits Synchrony System to FDA Stereotaxis (NYSE:STXS) announced that it has received CE mark for its Synchrony system and submitted it to the FDA.
Mountain Grass Unit Announces Initial 2026 Tour Dates After a breakout year in 2025, Mountain Grass Unit will embark on the 'Dog's Out The…
Alumni-Student Mentorship Program Launches Boise State's new alumni-student mentorship program will run from October 20, 2025, to April 24…
Love's Labour's Lost: Exploring Commitment Shakespeare's comedy "Love's Labour's Lost" provides a humorous exploration of how differently …
Jasmine Paolini's Remarkable Year in Asia Jasmine Paolini, Italy's sensation on the WTA Tour, continues her impressive Asia stretch with t…
Latest Developments in Telecom Broadcom is leading the charge on Wi-Fi 8. Bell Canada has unveiled a new three-year strategy.
Warburtons Expands Production with Roberts Bakery Site Acquisition Warburtons has acquired the specialty bread factory of Roberts Bakery i…
Americans Aim for Individual Honors at 2025 FIG Artistic World Championships Ten Americans, with nine Worlds medals between them, are prep…
Goldbug Governor: Ron DeSantis Blames Fed for Metal Valuation Surge Ron DeSantis isn't surprised by the surge in gold and silver values, a…
Cambridge Residents Prioritize Affordable Housing Almost half of Cantabrigians ranked "affordable housing" as the single most important is…
Cambridge Residents' Concerns About Upzoning One candidate notes that residents are having second thoughts about the implementation of mul…